Related articles

During cancer treatment, side effects can vary widely from person to person and change over time.
Fatigue, nausea, oral discomfort, nerve numbness, digestive issues, dry skin, and changes in memory or concentration are all commonly reported, yet no two patients experience them in exactly the same way.
Some side effects appear suddenly and last longer than expected.
Others follow a more recognizable pattern linked to treatment cycles.
Many patients assume, “My doctor should know how I’ve been feeling.”
In reality, medical teams care for many patients simultaneously, making it difficult to track the subtle, day-to-day changes each individual experiences.
For this reason, increasing numbers of patients are beginning to recognize that ongoing self-observation plays an important role in the recovery process.

During cancer treatment, side effects can vary greatly from person to person and often change over time.
Fatigue, nausea, mouth sores, nerve-related numbness or tingling, gastrointestinal discomfort, dry skin, and cognitive changes may all occur, but no two patients experience them in exactly the same way.
Some side effects appear suddenly and persist for extended periods, while others follow clear patterns related to treatment cycles.
Many patients assume, “My doctor should already know how I’m doing.”
In reality, clinicians manage a large number of consultations and follow-ups each day, making it difficult to recall the subtle and ongoing changes experienced by every individual.
At this point, a simple but consistent “cancer side effects journal” becomes an especially valuable supportive tool.
It is not merely a record, but a practical way for patients to better understand their body’s changes, communicate more precisely with their healthcare team, and monitor long-term effects even after treatment has ended.

After lung cancer treatment ends, one of the most noticeable issues for many patients is breathing becoming labored: shortness of breath when walking or climbing stairs, chest tightness during deep breaths, persistent dry cough, severe panting after activity, and even a feeling of chest compression when lying down or waking up coughing at night. These symptoms are very common in lung cancer patients, especially those who received chest radiotherapy, platinum-based chemotherapy (such as cisplatin or carboplatin), or lung lobectomy surgery, with incidence rates reaching 40–70%. It is not simply “stamina not yet recovered,” but direct damage from treatment to alveoli, airways, and pulmonary interstitium — one of the most typical and long-term sequelae after lung cancer treatment, significantly affecting physical endurance and quality of life.

After treatment ends, many patients worry most not about tumor recurrence, but about their body becoming “very prone to colds,” “slow wound healing,” or “small infections leading to prolonged fever.” This condition is medically known as “Treatment-Related Immunosuppression and Increased Infection Risk.” It is not simply “weaker constitution” or “getting older,” but the long-term suppression of the immune system by chemotherapy, radiotherapy, targeted therapy, or prolonged steroids. Lung cancer, lymphoma, leukemia, colorectal cancer, breast cancer, and ovarian cancer patients are particularly susceptible, and symptoms often persist for months to years — one of the most common and life-safety-impacting long-term side effects after treatment.

After treatment ends, many patients find the most frustrating issue is not physical pain, but the “foggy” feeling in their head: forgetting what they just said, getting distracted easily while reading or watching TV, processing things more slowly, struggling to find words, and even finding familiar work or household tasks feel difficult. This condition is medically known as “Cancer-Related Cognitive Impairment” (commonly called “chemo brain” or “chemo fog”). It is not simply “getting older” or “stress,” but the long-term impact of treatment on brain neurons, synapses, and the blood-brain barrier. Breast cancer, ovarian cancer, lymphoma, colorectal cancer, and patients treated with paclitaxel, doxorubicin, or cyclophosphamide are particularly prone to it, and symptoms often persist for months to years — one of the most common long-term side effects after treatment, affecting work, learning, and self-confidence the most.

After treatment ends, many patients discover their skin condition has changed completely from before: dryness, peeling, redness, itching, pigmentation, and even minor friction can cause easy breakage or inflammation. These changes not only affect appearance but also bring discomfort and emotional stress. Medically, this is often referred to as “Treatment-Related Dermatologic Toxicity and Chronic Skin Changes.” It is not simply “dry skin” or “allergy,” but the long-term impact of chemotherapy, radiotherapy, targeted therapy, or hormone therapy on the skin barrier, pigment cells, and blood vessels. Breast cancer, lung cancer, colorectal cancer, head and neck cancer, and melanoma patients are particularly prone to these issues, and symptoms often persist for months to years — one of the most common and quality-of-life-impacting long-term side effects after treatment.

After treatment ends, for many cancer patients, the most troubling issue is often not the tumor itself, but the “tingling, prickling, glove-like or sock-like” sensation in the hands and feet, weakness when holding objects, walking as if stepping on cotton, and sometimes difficulty sleeping at night due to intensified discomfort. Medically, this is called “Chemotherapy-Induced Peripheral Neuropathy” (CIPN). It is not simply “cold hands and feet” or “fatigue,” but a toxic nerve injury caused by certain chemotherapy drugs to the peripheral nerves. Patients treated with paclitaxel, oxaliplatin, bortezomib, or vinca alkaloid drugs are particularly prone to it, and the symptoms often persist for months to years, making it one of the most common and life-quality-impacting long-term side effects after treatment.